Faruqi & Faruqi, LLP Announces Preliminary Approval Of Settlement In Rihn v. ACADIA Pharmaceuticals Inc.


Faruqi & Faruqi, LLP, sole lead counsel,  is pleased to announce that the Court has preliminarily approved a settlement in Rihn v. ACADIA Pharmaceuticals Inc., Case No.: 15-CV-00575-BTM-DHB.  The settlement provides for a cash payment of $2.925 million in exchange for the release of all claims alleged in the action.  As a result, notice will be sent to class members to advise them of their rights to participate in, object to, or seek exclusion from the settlement.  The final fairness hearing is scheduled for October 3, 2017.

If you purchased ACADIA common stock and/or call options between November 10, 2014 and March 11, 2015, both dates inclusive, and would like to discuss your legal rights, call Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or send an e-mail to rgonnello@faruqilaw.com.

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885

Georgia

3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania